JPRN-UMIN000009267招募中1 期
Feasibility study of Anthracycline Based Regimen followed by Nab-Paclitaxel as adjuvant chemotherapy for elderly patients with breast cancer - FANAC study
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 60years-old 至 80years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1.History of severe allergy to nab-paclitaxel 2.Metachronous bilateral breast cancer 3.Active another cancer 4.History hypersensitivity reaction 5.Physician judged improper to entry this trial
研究者
相似试验
已完成
2 期
A feasibility study of Anthracycline-based regimen followed by Nab-Paclitaxel as adjuvant chemotherapy for breast cancer.(SBCCSG-32)Primary breast cancerJPRN-UMIN000012428Saitama Breast Cancer Clinical Study Group(SBCCSG)40
已完成
2 期
A feasibility study of sequential Anthracycline-based regimen and Nab-Paclitaxel / Trastuzumab followed by Trastuzumab as postoperative adjuvant chemotherapy for Her2 positive breast cancer.(SBCCSG-22)Primary breast cancerJPRN-UMIN000006085Saitama Breast Cancer Clinical Study Group(SBCCSG)30
尚未招募
不适用
Cardio-oncology studyPACTR20180400321843950
已完成
2 期
The AVICCI study: a feasibility study to assess the effects of AntiretroViral Intensification with Cenicriviroc for the management of HIV-associated Cognitive ImpairmentHIVInfections and InfestationsHuman immunodeficiency virus [HIV] diseaseISRCTN18166185Imperial College London7
进行中（未招募）
1 期
A phase II feasibility study to assess changes in patients who have been identified as having cognitive function impairment following the addition of a new drug to an existing effective regime of three HIV antiretrovirals drugsEUCTR2015-002955-85-GBImperial College London7